Passion or the desire to make a difference alone cannot bring about radical changes in the world of medtech. Money and the right guidance are equally crucial. That’s where venture capitalist firms—especially RiverVest Venture Partners—come in.
RiverVest, with offices in St. Louis and Cleveland, has stuck it out in the field of early-stage life science investing when others have fled, unwilling to invest in medtech companies that have high regulatory hurdles. The firm’s model of scoping out opportunities, and then founding and incubating companies around interesting technologies has served it and the medtech world well. In 2012 and 2013, RiverVest saw four portfolio companies make exits, the highest of any other venture firm that invests in medical devices, according to PrivCo, a provider of financial intelligence on private companies.
Here are some of the notable exits RiverVest has had in the medical device realm in recent years:
|No. 8||No. 6|
|Meet more agents of change in medtech at the MD&M East tradeshow and conference in New York City June 9–12, 2014.|
[image courtesy of SHEELAMOHAN/FREEDIGITALPHOTOS.NET]